Consensus Evercore Inc.

Stocks

EVR

US29977A1051

Investment Banking & Brokerage Services

Market Closed - NYSE 00:00:02 27/10/2026 +04			5-day change	1st Jan Change
257.40 ^USD	+2.19%		+3.81%	-24.35%

10-26	Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on	RE
10-22	LSEG to buy Octus in $3.5 billion deal to shield from AI disruption	RE

Evolution of the Average Target: Evercore Inc.

Evolution of the Target Price: Evercore Inc.

Changes in Analyst Recommendations: Evercore Inc.

b23925d5c.yB2O4e_6NEbsgHHvCr2jKRw0nwQlzwD0DzNCKYLA9kM.hFTnr7yfQA3etT6cbYnKa1RW2z1NulCjTWQURfGKunWYWvvTuoBeLY7MGg~d40327b29a55b28087aead02008b7422

Analysts' recommendations: Evercore Inc.

10-12	BofA Securities Adjusts Evercore Price Target to $367 From $389, Maintains Buy Rating	MT
10-07	UBS Adjusts Price Target on Evercore to $318 From $359, Maintains Neutral Rating	MT
09-04	Evercore's Valuation Discount to Peers Could Narrow, Deutsche Bank Says	MT
07-30	UBS Adjusts Price Target on Evercore to $359 From $350, Maintains Neutral Rating	MT
07-09	Houlihan Lokey Estimates Cut by Morgan Stanley as Sponsor M&A Recovery Lags	MT
07-08	UBS Adjusts Price Target on Evercore to $350 From $330, Maintains Neutral Rating	MT
04-30	UBS Adjusts Evercore Price Target to $330 From $313, Maintains Neutral Rating	MT
04-30	Morgan Stanley Cuts Price Target on Evercore to $376 From $384, Keeps Equalweight Rating	MT
04-09	Wealth Brokers, Investment Banks Faced Uneven First-Quarter Activity, UBS Says	MT
03-12	UBS Adjusts Evercore Price Target to $313 From $383, Maintains Neutral Rating	MT
02-05	UBS Adjusts Price Target on Evercore to $383 From $363, Maintains Neutral Rating	MT
02-05	Morgan Stanley Lifts Price Target on Evercore to $381 From $376, Keeps Equalweight Rating	MT
01-26	BofA Securities Initiates Coverage on Evercore With Buy Rating, $435 Price Target	MT
01-16	William O'Neil Initiates Coverage on Evercore With Buy Rating	MT
01-07	UBS Adjusts Price Target on Evercore to $363 From $340, Maintains Neutral Rating	MT
12-08	Jefferies to Benefit From Pickup in Sponsor Activity in 2026, Morgan Stanley Says	MT
12-08	Morgan Stanley Downgrades Evercore to Equalweight From Overweight, Keeps $373 Price Target	MT
30/10/25	Morgan Stanley Lowers Price Target on Evercore to $373 From $397, Keeps Overweight Rating	MT
29/10/25	Investment banking firm Evercore beats Q3 profit beats estimates	RE
09/10/25	Evercore Offers Leverage to M&A Rebound, Deutsche Bank Says	MT
09/10/25	Deutsche Bank Initiates Evercore at Buy With $400 Price Target	MT
07/10/25	We Are at Beginning of Multi-Year M&A Cycle: Schlosstein	MT
03/10/25	BMO Capital Initiates Coverage on Evercore With Market Perform Rating, $358 Price Target	MT
31/07/25	Morgan Stanley Raises Price Target on Evercore to $315 From $312, Keeps Overweight Rating	MT
30/07/25	Investment bank Evercore beats Q2 revenue estimates, announces acquisition of Robey Warshaw	RE

More recommendations

Other Investment Banking & Brokerage Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	EVERCORE INC.					+31.89%
	MORGAN STANLEY					+17.58%
	THE GOLDMAN SACHS GROUP, INC.					+17.75%
	CITIGROUP INC.					+24.95%
	CHARLES SCHWAB					+29.82%
	BANCO BTG PACTUAL S.A.					-5.65%
	CITIC SECURITIES COMPANY LIMITED					+44.66%
	EAST MONEY INFORMATION CO.,LTD.					+33.92%
	GUOTAI HAITONG SECURITIES CO., LTD.					+51.8%
	INTERACTIVE BROKERS GROUP, INC.					+30.37%
	Average					+27.71%
	Weighted average by Cap.					+22.61%